A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

NCT01181167 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention
Venous Thromboembolism

Interventions

DRUG: edoxaban
DRUG: enoxaparin sodium

Sponsor

Daiichi Sankyo Co., Ltd.